David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Cambridge Quarterly of Healthcare Ethics 9 (03):365-377 (2000)
The therapy-enhancement distinction occupies a central place in contemporary discussions of human genetics and has been the subject of much debate. At a recent conference on gene therapy policy, scientists predicted that within a few years researchers will develop techniques that can be used to enhance human traits. In thinking about the morality of genetic interventions, many writers have defended somatic gene therapy, and some have defended germline gene therapy, but only a handful of writers defend genetic enhancement, or even give it a fair hearing. The mere mention of genetic enhancement makes many people cringe and brings to mind the Nazi eugenics programs, Aldous Huxley's BraveNewWorld, or the recent movie Although many people believe that gene therapy has morally legitimate medical uses, others regard genetic enhancement as morally problematic or decidedly evil
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Julian Savulescu, Melanie Hemsley & Ainsley Newson Andbennett Foddy (2006). Behavioural Genetics: Why Eugenic Selection is Preferable to Enhancement. Journal of Applied Philosophy 23 (2):157–171.
Similar books and articles
Eric T. Juengst (1997). Can Enhancement Be Distinguished From Prevention in Genetic Medicine? Journal of Medicine and Philosophy 22 (2):125-142.
Robert Sparrow (2010). Better Than Men?: Sex and the Therapy/Enhancement Distinction. Kennedy Institute of Ethics Journal 20 (2):pp. 115-144.
Nils Holtug (2011). Equality and the Treatment-Enhancement Distinction. Bioethics 25 (3):137-144.
Maartje Schermer (2007). The Dynamics of the Treatment-Enhancement Distinction: ADHD as a Case Study. Philosophica 79:25-37.
Walter Glannon (2001). Genes and Future People: Philosophical Issues in Human Genetics. Westview Press.
David Resnik (1994). Debunking the Slippery Slope Argument Against Human Germ-Line Gene Therapy. Journal of Medicine and Philosophy 19 (1):23-40.
Vincent Menuz, Thierry Hurlimann & Béatrice Godard (2013). Is Human Enhancement Also a Personal Matter? Science and Engineering Ethics 19 (1):161-177.
Patrick Grüneberg (2012). From Therapy and Enhancement to Assistive Technologies: An Attempt to Clarify the Role of the Sports Physician. Sport, Ethics and Philosophy 6 (4):480-491.
W. French Anderson (1989). Human Gene Therapy: Why Draw a Line? Journal of Medicine and Philosophy 14 (6):681-693.
Nick Bostrom & Rebecca Roache (2007). Ethical Issues in Human Enhancement. In J. Ryberg, T. Petersen & C. Wolf (eds.), New Waves in Applied Ethics. Palgrave Macmillan. 120--152.
Ingmar Persson & Julian Savulescu (2013). Getting Moral Enhancement Right: The Desirability of Moral Bioenhancement. Bioethics 27 (3):124-131.
Thomas Douglas (2008). Moral Enhancement. Journal of Applied Philosophy 25 (3):228-245.
Guy Kahane & Julian Savulescu (2012). The Concept of Harm and the Significance of Normality. Journal of Applied Philosophy 29 (3):318.
John Harris (2011). Moral Enhancement and Freedom. Bioethics 25 (2):102-111.
Ray Moseley (1991). Commentary: Maintaining the Somatic/Germ-Line Distinction: Some Ethical Drawbacks. Journal of Medicine and Philosophy 16 (6):641-647.
Added to index2010-08-24
Total downloads110 ( #9,052 of 1,098,981 )
Recent downloads (6 months)16 ( #9,916 of 1,098,981 )
How can I increase my downloads?